Submitted by Anonymous (not verified) on 9 March 2026 - 10:35
Opinion/decision on a Paediatric investigation plan (PIP): Omvoh, mirikizumab, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Gastrointestinal disorders, PIP number: EMA/PE/0000232930
Source: